LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
PMCBCIK 0001157075

PharmaCyte Biotech, Inc.

13 transactions by 5 insiders, from April 25, 2025 to March 31, 2026.

Transactions
135 insiders
Bought · P
$129Kopen market
Sold · S
Nonenobody sold on the open market
Net
+$129Knet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Jonathan SchechterDir4—$48K—
Michael M. AbecassisDir4———
Joshua SilvermanCEO3—$80K—
Robert WeinsteinDir1———
Wayne Remell WalkerDir1———

All transactions

13 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Robert WeinsteinDirDERIVMar 31A119,170$0.00—?
Wayne Remell WalkerDirDERIVMar 31A119,170$0.00—?
Jonathan SchechterDirDERIVMar 31A119,170$0.00—?
Michael M. AbecassisDirDERIVMar 31A119,170$0.00—?
Joshua SilvermanCEOJan 7P40,000$0.83$33K
Joshua SilvermanCEOJan 6P30,000$0.79$24K
Joshua SilvermanCEOJan 5P30,000$0.78$23K
Jonathan SchechterDirJan 7P20,000$0.84$17K
Jonathan SchechterDirJan 6P20,000$0.79$16K
Jonathan SchechterDirJan 5P20,000$0.78$16K
Michael M. AbecassisDirDERIVApr 25A63,233$0.00—?
Michael M. AbecassisDirDec 12F16,875$1.02$17K
Michael M. AbecassisDirDec 12A37,500$0.00—